Thus, in this study, we produced the fusion protein (RGD)3-tTF which was consisted of tTF and triple peptides of RGD as the carrier of tTF for targeting tumor vasculature in the treatment of mice colorectal carcinoma. This evidence concerns the gene RHOH and neoplasm.